Mereo BioPharma Group plc MREO
0.30 USD +0.01 (+3.64%)
Nov 4, 2026, 3:40 PM EST
0.281 Day range 0.3073
0.20 52-week range 2.37
- YTD
- -27.67%
- 1 year
- -83.06%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 500.00K | 0 | 10.00M | 0 | 45.58M | |
| 367.00K | 0 | 7.43M | 1.15M | 23.20M | |
| -40.41M | -47.36M | -28.42M | -54.43M | -26.03M | |
| -41.88M | -43.25M | -29.47M | -42.22M | 15.91M | |
| -0.25 | -0.30 | -0.20 | -0.35 | -0.312 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 40.99M | 69.80M | 57.42M | 68.18M | 117.87M | |
| 45.92M | 76.39M | 66.50M | 77.41M | 158.02M | |
| 5.00M | 15.42M | 15.96M | 26.01M | 48.02M | |
| 202.00K | 6.43M | 5.95M | 15.37M | 20.95M | |
| 40.92M | 60.97M | 50.54M | 51.40M | 110.00M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -30.97M | -32.83M | -21.13M | -48.82M | -6.55M | |
| -20.00K | -699.00K | -419.00K | 1.99M | -526.25K | |
| 327.00K | 46.15M | 7.97M | 200.00K | 97.06M | |
| -20.00K | 0 | 0 | -13.00K | -668.75K | |
| -30.66M | 12.61M | -10.76M | -46.63M | 89.99M |